Format

Send to

Choose Destination
Surgery. 2010 Dec;148(6):1313-5. doi: 10.1016/j.surg.2010.09.023.

Summary statement: utility of molecular marker testing in thyroid cancer.

Author information

1
Division of Endocrine Surgery, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. yipl@upmc.edu

Abstract

The use of molecular markers for thyroid cancer diagnosis, prognosis, and surveillance have been an exciting area of study and change. Recent investigative focus on promising new markers will very likely lead to improvements in the diagnostic utility of fine needle aspiration biopsy (FNAB) in predicting malignancy, as well as provide more accurate prognostic information pre- and postoperatively. The 2010 Annual Meeting of the American Association for Endocrine Surgeons featured a symposium dedicated to molecular marker testing in thyroid cancer and its potential clinical applicability.

PMID:
21134567
PMCID:
PMC3052981
DOI:
10.1016/j.surg.2010.09.023
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center